Roivant Sciences Ltd. Business Operations Contracts & Agreements
8 Contracts & Agreements
- Collaboration Agreements (4 contracts)
- Supply Agreements (3)
- Termination Agreements (1)
- License and Collaboration Agreement dated as of November 21, 2022 (Filed With SEC on February 13, 2023)
- Master Commercial Manufacturing Supply Agreement, dated as of July 1, 2022, by and between Dermavant Sciences GmbH and Thermo Fisher Scientific Cork Limited (Filed With SEC on November 14, 2022)
- Partial Termination and Supplementary Fee Agreement relating to the Clinical Supply Agreement and Commercial Supply Agreement, dated as of July 25, 2022, by and between... (Filed With SEC on November 14, 2022)
- Amendment No. 1 to License and Collaboration Agreement, dated as of June 10, 2022, by and between Pfizer Inc. and Priovant, Inc (Filed With SEC on June 28, 2022)
- License and Collaboration Agreement, dated as of September 13, 2021, by and between Pfizer Inc. and Priovant, Inc (Filed With SEC on June 28, 2022)
- Commercial Supply and Manufacturing Agreement, dated April 1, 2019, by and between Dermavant Sciences GmbH and GlaxoSmithKline (Filed With SEC on May 14, 2021)
- Clinical Supply and Manufacturing Agreement, dated August 20, 2018, by and between Dermavant Sciences GmbH and GlaxoSmithKline (Filed With SEC on May 14, 2021)
- Collaboration and License Agreement, dated as of January 15, 2020, by and between Dermavant Sciences GmbH and Japan Tobacco Inc (Filed With SEC on May 14, 2021)